View by type:
Articles (3344)
Could drugs to prevent Long COVID finally be within reach?
Two new studies have suggested that existing diabetes and antiviral drugs could be repurposed to prevent symptoms of COVID-19.
What next-gen Covid-19 vaccines might look like
From building up defenses in the nose to slowing down a virus’s ability to make copies of itself, scientists are rolling out a raft of creative approaches to fighting infection.
“We need to reach every child”: How Uganda’s routine immunisation program climbed back from COVID-19
Resilience can look like a canny financial strategy or a health worker crawling up a rickety ladder, finds John Agaba in Kampala.
Countries (77)
Documents (9002)
Early Notice of RFP Opportunities for Gavi Evaluations
The Centralised Evaluation Team (CET) within the Evaluation and Learning Unit (EvLU) at Gavi is responsible for the commissioning and day-to-day management of evaluations, including ensuring the utility, quality and timely delivery of evaluation reports and disseminating the findings. The document provides information on the current pipeline of centralized evaluations to be commissioned in 2023 through future RFPs.
CSO and Local Partners Fund Manager
Gavi is seeking firms that will support expanding and strengthening Gavi’s capacity to engage with CSOs and local partners by establishing a new mechanism for engaging CSOs and local partners by outsourcing the full, or part of, the end-to-end grants and contract management processes.
RFP: Measles Rapid Diagnostic Test Deployment Pilot Study
Gavi The Vaccine Alliance is seeking a firm that will provide support in improving availability and use of fit-for-purpose measles IgM Rapid Diagnostic Tests (RDTs). Such measles IgM RDTs are expected to be available by the 1st quarter of 2024. Efforts to improve access to and use of measles IgM RDTs will be aided by measures including pooling procurement across low- and middle-income countries eligible for Gavi funding support and supporting the development of guidance on how to best deploy such tests to guide immunization programme decision making.
